HemaSphere
(Jun 2022)
S193: GENOMIC AND FUNCTIONAL IMPACT OF TP53 INACTIVATION IN JAK2V617F MYELOPROLIFERATIVE NEOPLASMS: A TRANSGENIC MOUSE MODEL APPROACH.
- P. GOU,
- D. LIU,
- E. Lauret,
- N. Maslah,
- V. Montcuquet,
- V. meignin,
- J.-J. Kiladjian,
- B. Cassinat,
- S. Giraudier
Affiliations
- P. GOU
- 1 U1131, 25Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, INSERM
- D. LIU
- 1 U1131, 25Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, INSERM
- E. Lauret
- 3 U1131, INSERM Univrsité de Paris and APHP
- N. Maslah
- 3 U1131, INSERM Univrsité de Paris and APHP
- V. Montcuquet
- 4 Animal Facility Unit, Université de Paris
- V. meignin
- 5 Histo-pathological department, Hôpital Saint Louis
- J.-J. Kiladjian
- 6 Centre Investigations Cliniques, Hôpital Saint-Louis, Paris, France, INSERM Univrsité de Paris and APHP, Paris, France
- B. Cassinat
- 3 U1131, INSERM Univrsité de Paris and APHP
- S. Giraudier
- 3 U1131, INSERM Univrsité de Paris and APHP
- DOI
-
https://doi.org/10.1097/01.HS9.0000843664.23956.b2
- Journal volume & issue
-
Vol. 6
pp.
94
– 95
WeChat QR code